The determinants of innovative capacity in the medical sector in Central Europe and across the European Union

    Scott W. Hegerty Affiliation
    ; Marzenna Weresa Affiliation


The recent COVID-19 crisis, as well as the resulting international response, have demonstrated the importance of medical innovation in meeting current and future health challenges. Yet capacity for innovation differs from country to country, and policymakers are wise to find ways to increase each nation’s ability to generate new solutions. This study examines medical innovation, measured as patents per capita, for 27 EU countries from 2004 to 2018. Modelling innovation as a function of international and domestic macroeconomic variables, government and private-sector R&D, the rate of return to physical and human capital, and a measure of risk, a dynamic panel analysis finds that real-exchange-rate volatility reduces patent applications for some countries, particularly in Central and Eastern Europe. The response to the explanatory variables differs by countries’ overall innovation levels, with innovation in weaker innovators reduced by risk and increased by higher education levels. In stronger innovators, the internal rate of return most strongly drives innovation, suggesting that this process more closely resembles “traditional” investments.

First published online 15 November 2022

Keyword : medical innovation, innovative capacity, sectoral innovation system, European Union, Central and Eastern Europe

How to Cite
Hegerty, S. W., & Weresa, M. (2023). The determinants of innovative capacity in the medical sector in Central Europe and across the European Union. Technological and Economic Development of Economy, 29(1), 74–90.
Published in Issue
Jan 20, 2023
Abstract Views
PDF Downloads
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.


Adams, J. (2000). Risk. Routledge.

Arellano, M., & Bond, S. (1991). Some tests of specification for panel data: Monte Carlo evidence and an application to employment equations. The Review of Economic Studies, 58(2), 277–297.

Breschi, S., & Malerba, F. (1997). Sectoral systems of innovation: Technological regimes, Schumpeterian dynamics and spatial boundaries. In C. Edquist (Ed.), Systems of innovation (pp. 139–156). Frances Pinter.

Chan, T. Y., Hamilton, B. H., & Papageorge, N. W. (2016). Health, risky behaviour and the value of medical innovation for infectious disease. The Review of Economic Studies, 83(4), 1465–1510.

Clark, J., Freeman, C., & Soete, L. (1981). Long waves, inventions, and innovations. Futures, 13(4), 308–322.

Consoli, D., & Mina, A. (2009). An evolutionary perspective on health innovation systems. Journal of Evolutionary Economics, 19, 297–319.

Di Pietro, G., Biagi, F., Dinis Mota Da Costa, P., Karpinski, Z., & Mazza, J. (2020). The likely impact of COVID-19 on education: Reflections based on the existing literature and recent international datasets. Publications Office of the European Union, Luxembourg.

Doyle, E., & O’Connor, F. (2013). Innovation capacities in advanced economies: Relative performance of small open economies. Research in International Business and Finance, 27(1), 106–123.

Dziallas, M., & Blindt, K. (2019). Innovation indicators throughout the innovation process: An extensive literature analysis. Technovation, 80–81, 3–29.

European Commission. (2018). European Innovation Scoreboard 2018. EIS. Publications Office of the European Union, Luxembourg. Retrieved August 13, 2021, from

European Commission. (2021). European Innovation Scoreboard 2021. EIS. Publications Office of the European Union, Luxembourg.

Francois, P., & Lloyd-Ellis, H. (2003). Animal spirits through creative destruction. American Economic Review, 93(3), 530–550.

Frankovic, I., Kuhn, M., & Wrzeszczak, S. (2020). Medical innovation and its diffusion: Implications for economic performance and welfare. Journal of Macroeconomics, 66, 103262.

Furman, J. L., Porter, M. E., & Stern, S. (2002). The determinants of national innovative capacity. Research Policy, 31(6), 899–933.

Furman, J. L., & Hayes, R. (2004). Catching up or standing still? National innovative productivity among “follower” countries, 1978–1999. Research Policy, 33(9), 1329–1354.

Grebel, T., & Wilfer, T. (2010). Innovative cardiological technologies: A model of technology adoption, diffusion and competition. Economics of Innovation and New Technology, 19(4), 325–347.

Griliches, Z. (1990). Patent statistics as economic indicators: A survey. Journal of Economic Literature, 28(4), 1661–1707.

Holton, G. A. (2004). Defining risk. Financial Analysts Journal, 60(6), 19–25.

Hong, J., Hong, S., Wang, L., Xu, Y., & Zhao, D. (2015). Government grants, private R&D funding and innovation efficiency in transition economy. Technology Analysis & Strategic Management, 27(9), 1068–1096.

Hsu, P.-H., Tian, X., & Xu, Y. (2014) Financial development and innovation: Cross-country evidence. Journal of Financial Economics, 112(1), 116–135.

Hu, M.-C., & Mathews, J. A. (2005). National innovative capacity in East Asia. Research Policy, 34(9), 1322–1349.

Jeon, S.-H., & Pohl, R. V. (2019). Medical innovation, education, and labor market outcomes of cancer patients. Journal of Health Economics, 68, 102228.

Kelly, B., Papanikolaou, D., Seru, A., & Taddy, M. (2020). Measuring technological innovation over the long run (National Bureau of Economic Research, Working Paper 25266). Cambridge, MA.

Ketels, C., & Clinch, J. P. (2020). Acting now while preparing for tomorrow: Competitiveness upgrading under the shadow of COVID-19 (ISC Working Paper, April 29). Institute for Strategy and Competitiveness. Harvard Business School.

Knight, F. (1964). Risk, uncertainty and profit. Augustus M. Kelley.

Kravtsova, V., & Radosevic, S. (2012). Are systems of innovation in Eastern Europe efficient? Economic Systems, 36(1), 109–126.

Levaggi, R., & Pertile, P. (2020). Which valued-based price when patients are heterogeneous? Health Economics, 29(8), 923–935.

Malerba, F. (2005). Sectoral systems of innovation: A framework for linking innovation to the knowledge base, structure and dynamics of sectors. Economics of Innovation and New Technology, 14(1–2), 63–82.

Malik, S. (2020). Macroeconomic determinants of innovation: Evidence from Asian countries. Global Business Review, 1–15.

Mensch, G. (1979). Stalemate in technology: Innovations overcome the depression. Cambridge, MA: Ballinger.

Moro, M. A., Andersen, M. M., Smets, B. F., & McKnight, U. S. (2019). National innovative capacity in the water sector: A comparative assessment between China and Europe. Journal of Cleaner Production, 210, 325–342.

Nagaoka, S., Motohashi, K., & Goto, A. (2010). Patent statistics as an innovation indicator. In H. Bronwyn & N. Rosenberg (Eds.), Handbook of the economics of innovation (vol. 2, pp. 1083–1127). Elsevier.

Pavitt, K. (1985). Patent statistics as indicators of innovative activities: Possibilities and problems. Scientometrics, 7(1–2), 77–99.

Radosevic, S., Yoruk, D. E., & Yoruk, E. (2019). Technology upgrading and growth in Central and Eastern Europe. In G. Gorzelak (Ed.), Social and economic development in Central and Eastern Europe. Stability and Change after 1990 (pp. 178–204). Routledge.

Rosa, E., Renn, O., & McCright, A. (2014). The risk society revisited: Social theory and governance. Temple University Press.

Schumpeter, J. (1950). Capitalism, socialism and democracy (3rd ed.). Allen & Unwin.

Stojčić, N. (2021). Collaborative innovation in emerging innovation systems: Evidence from Central and Eastern Europe. The Journal of Technology Transfer, 46, 531–562.

van de Wetering, G., Woertman, W. H., & Adang, E. M. (2012). Time to incorporate time in cost-effectiveness analysis. The European Journal of Health Economics, 13, 223–226.

Willemé, P., & Dumont, M. (2015). Machines that Go “Ping”: Medical technology and health expenditures in OECD countries. Health Economics, 24(8), 1027–1041.

Willet, A. (1951). The economic theory of risk and insurance. University of Pennsylvania Press.

Zang, L., Xiong, F., Lao, X., & Gao, Y. (2019). Does governance efficiency matter for national innovative capacity? One tale from different countries. Technology Analysis & Strategic Management, 31(2), 239–252.